Annual SGA
$31.23 M
+$19.74 M+171.83%
December 31, 2023
Summary
- As of February 12, 2025, BLRX annual SGA is $31.23 million, with the most recent change of +$19.74 million (+171.83%) on December 31, 2023.
- During the last 3 years, BLRX annual SGA has risen by +$26.55 million (+566.74%).
- BLRX annual SGA is now at all-time high.
Performance
BLRX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$6.94 M
-$1.10 M-13.69%
September 1, 2024
Summary
- As of February 12, 2025, BLRX quarterly SGA is $6.94 million, with the most recent change of -$1.10 million (-13.69%) on September 1, 2024.
- Over the past year, BLRX quarterly SGA has stayed the same.
- BLRX quarterly SGA is now -27.90% below its all-time high of $9.63 million, reached on September 30, 2023.
Performance
BLRX Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.57 B
-$19.92 M-1.29%
September 1, 2024
Summary
- As of February 12, 2025, BLRX TTM SGA is -$1.57 billion, with the most recent change of -$19.92 million (-1.29%) on September 1, 2024.
- Over the past year, BLRX TTM SGA has dropped by -$1.60 billion (-4968.67%).
- BLRX TTM SGA is now -1567.83% below its all-time high of -$94.10 million.
Performance
BLRX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
BLRX Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +171.8% | 0.0% | -4968.7% |
| 3 y3 years | +566.7% | 0.0% | -4968.7% |
| 5 y5 years | +441.3% | 0.0% | -4968.7% |
BLRX Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +492.7% | -27.9% | +385.5% | -32.0% | at low |
| 5 y | 5-year | at high | +579.6% | -27.9% | +649.8% | -65.4% | at low |
| alltime | all time | at high | +649.3% | -27.9% | +649.8% | -1567.8% | at low |
BioLineRx Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $6.94 M(-13.7%) | $32.23 M(-7.7%) |
| Jun 2024 | - | $8.04 M(+4.1%) | $34.92 M(+3.4%) |
| Mar 2024 | - | $7.73 M(-18.8%) | $33.79 M(+8.2%) |
| Dec 2023 | $31.23 M(+171.8%) | $9.52 M(-1.2%) | $31.23 M(+17.2%) |
| Sep 2023 | - | $9.63 M(+39.4%) | $26.64 M(+35.1%) |
| Jun 2023 | - | $6.91 M(+33.6%) | $19.72 M(+31.3%) |
| Mar 2023 | - | $5.17 M(+4.9%) | $15.02 M(+30.7%) |
| Dec 2022 | $11.49 M(+118.0%) | $4.93 M(+81.9%) | $11.49 M(+43.8%) |
| Sep 2022 | - | $2.71 M(+22.7%) | $7.99 M(+21.5%) |
| Jun 2022 | - | $2.21 M(+34.2%) | $6.58 M(+14.5%) |
| Mar 2022 | - | $1.64 M(+15.0%) | $5.74 M(+9.0%) |
| Dec 2021 | $5.27 M(+12.5%) | $1.43 M(+10.5%) | $5.27 M(+5.1%) |
| Sep 2021 | - | $1.29 M(-5.8%) | $5.01 M(+2.6%) |
| Jun 2021 | - | $1.37 M(+17.3%) | $4.88 M(+10.1%) |
| Mar 2021 | - | $1.17 M(-0.3%) | $4.44 M(-5.3%) |
| Dec 2020 | $4.68 M(+1.9%) | $1.18 M(+0.9%) | $4.68 M(+0.6%) |
| Sep 2020 | - | $1.17 M(+25.8%) | $4.66 M(+1.7%) |
| Jun 2020 | - | $926.00 K(-34.7%) | $4.58 M(-5.2%) |
| Mar 2020 | - | $1.42 M(+23.4%) | $4.83 M(+5.0%) |
| Dec 2019 | $4.59 M(-20.4%) | $1.15 M(+5.9%) | $4.59 M(-12.1%) |
| Sep 2019 | - | $1.08 M(-7.7%) | $5.23 M(-1.9%) |
| Jun 2019 | - | $1.18 M(-0.9%) | $5.33 M(-1.3%) |
| Mar 2019 | - | $1.19 M(-33.5%) | $5.40 M(-6.5%) |
| Dec 2018 | $5.77 M(+1.2%) | $1.78 M(+50.5%) | $5.77 M(+6.0%) |
| Sep 2018 | - | $1.19 M(-4.7%) | $5.44 M(-3.9%) |
| Jun 2018 | - | $1.24 M(-20.3%) | $5.66 M(+2.0%) |
| Mar 2018 | - | $1.56 M(+7.1%) | $5.55 M(-2.7%) |
| Dec 2017 | $5.70 M | $1.46 M(+3.7%) | $5.70 M(+0.8%) |
| Sep 2017 | - | $1.40 M(+23.9%) | $5.66 M(-2.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2017 | - | $1.13 M(-33.8%) | $5.79 M(+0.1%) |
| Mar 2017 | - | $1.71 M(+21.3%) | $5.78 M(+8.9%) |
| Dec 2016 | $5.31 M(+13.4%) | $1.41 M(-8.1%) | $5.31 M(+2.9%) |
| Sep 2016 | - | $1.53 M(+36.2%) | $5.16 M(+10.9%) |
| Jun 2016 | - | $1.13 M(-9.0%) | $4.65 M(-3.1%) |
| Mar 2016 | - | $1.24 M(-2.0%) | $4.80 M(+2.6%) |
| Dec 2015 | $4.68 M(-12.9%) | $1.26 M(+22.9%) | $4.68 M(-10.3%) |
| Sep 2015 | - | $1.03 M(-19.5%) | $5.22 M(-1.3%) |
| Jun 2015 | - | $1.27 M(+14.2%) | $5.29 M(+3.0%) |
| Mar 2015 | - | $1.12 M(-38.0%) | $5.13 M(-4.5%) |
| Dec 2014 | $5.37 M(+14.5%) | $1.80 M(+64.3%) | $5.37 M(+11.9%) |
| Sep 2014 | - | $1.10 M(-2.1%) | $4.80 M(+3.1%) |
| Jun 2014 | - | $1.12 M(-17.5%) | $4.66 M(-3.3%) |
| Mar 2014 | - | $1.36 M(+10.5%) | $4.82 M(+3.9%) |
| Dec 2013 | $4.69 M(+2.6%) | $1.23 M(+29.2%) | $4.63 M(-6.3%) |
| Sep 2013 | - | $951.20 K(-25.6%) | $4.95 M(+0.0%) |
| Jun 2013 | - | $1.28 M(+8.9%) | $4.95 M(+6.0%) |
| Mar 2013 | - | $1.18 M(-23.8%) | $4.67 M(+0.4%) |
| Dec 2012 | $4.57 M(+9.7%) | $1.54 M(+62.1%) | $4.65 M(+14.0%) |
| Sep 2012 | - | $951.00 K(-4.7%) | $4.07 M(-0.4%) |
| Jun 2012 | - | $997.70 K(-13.6%) | $4.09 M(-8.2%) |
| Mar 2012 | - | $1.16 M(+19.1%) | $4.46 M(+2.4%) |
| Dec 2011 | $4.17 M(-23.4%) | $969.60 K(+0.0%) | $4.35 M(-19.9%) |
| Sep 2011 | - | $969.40 K(-28.9%) | $5.43 M(-2.3%) |
| Jun 2011 | - | $1.36 M(+30.0%) | $5.56 M(+3.8%) |
| Mar 2011 | - | $1.05 M(-48.7%) | $5.36 M(+0.0%) |
| Dec 2010 | $5.44 M | $2.05 M(+86.8%) | $5.36 M(+61.9%) |
| Sep 2010 | - | $1.10 M(-5.8%) | $3.31 M(+49.6%) |
| Jun 2010 | - | $1.16 M(+10.9%) | $2.21 M(+110.9%) |
| Mar 2010 | - | $1.05 M | $1.05 M |
FAQ
- What is BioLineRx annual SGA?
- What is the all time high annual SGA for BioLineRx?
- What is BioLineRx annual SGA year-on-year change?
- What is BioLineRx quarterly SGA?
- What is the all time high quarterly SGA for BioLineRx?
- What is BioLineRx quarterly SGA year-on-year change?
- What is BioLineRx TTM SGA?
- What is the all time high TTM SGA for BioLineRx?
- What is BioLineRx TTM SGA year-on-year change?
What is BioLineRx annual SGA?
The current annual SGA of BLRX is $31.23 M
What is the all time high annual SGA for BioLineRx?
BioLineRx all-time high annual SGA is $31.23 M
What is BioLineRx annual SGA year-on-year change?
Over the past year, BLRX annual SGA has changed by +$19.74 M (+171.83%)
What is BioLineRx quarterly SGA?
The current quarterly SGA of BLRX is $6.94 M
What is the all time high quarterly SGA for BioLineRx?
BioLineRx all-time high quarterly SGA is $9.63 M
What is BioLineRx quarterly SGA year-on-year change?
Over the past year, BLRX quarterly SGA has changed by $0.00 (0.00%)
What is BioLineRx TTM SGA?
The current TTM SGA of BLRX is -$1.57 B
What is the all time high TTM SGA for BioLineRx?
BioLineRx all-time high TTM SGA is -$94.10 M
What is BioLineRx TTM SGA year-on-year change?
Over the past year, BLRX TTM SGA has changed by -$1.60 B (-4968.67%)